Skip to main content
. 2023 Aug 11;2023(8):CD002292. doi: 10.1002/14651858.CD002292.pub4

ChiCTR‐IOR‐15007146.

Methods Randomised controlled trial
Participants People with bullous pemphigoid
Interventions Control group: 0.05% halometasone cream daily
Treatment group: 0.05% halometasone cream daily plus low‐dose systemic steroids
Outcomes Efficacy of low‐dose systemic steroids combined with topical steroids in the treatment of bullous pemphigoid and risk factors for treatment‐refractory patients
Notes Finalised study; no data available. We contacted authors in July 2020, but received no response.
panmeng@medmail.com.cn